EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Vanishing white matter disease (VWM) is a rare, inherited leukodystrophy caused by mutations in the gene encoding translation initiation factor 2B (eIF2B).
• While the clinical manifestations of VWM are documented, the specific cellular impacts of eIF2B gene mutations on neural cells remain largely unexplored.
• Understanding these cellular consequences is crucial for elucidating VWM pathogenesis.

Purpose of the Study:

• To investigate the cellular effects of mutations in the EIF2B5 gene, a subunit of eIF2B, on neural cells in VWM.
• To determine the impact of these mutations on oligodendrocyte and astrocyte development and function.
• To explore the potential role of astrocyte dysfunction in VWM pathology.

Main Methods:

• Established primary cell cultures from the brain of a VWM patient with EIF2B5 mutations.
• Assessed oligodendrocyte and astrocyte generation and characteristics in vitro.
• Utilized RNA interference (RNAi) to target EIF2B5 in normal human glial progenitors.
• Examined astrocyte presence (GFAP+) in vivo lesions.

Main Results:

• Normal-appearing oligodendrocytes were successfully generated in vitro from VWM patient-derived cells, despite extensive demyelination.
• Astrocyte generation was severely compromised; few GFAP-expressing (GFAP+) astrocytes were present in cultures and in vivo lesions.
• The generated astrocytes exhibited abnormal morphologies and antigenic phenotypes.
• RNAi targeting of EIF2B5 significantly inhibited GFAP+ cell induction from glial progenitors.

Conclusions:

• Mutations in EIF2B5 disrupt astrocyte development and function in VWM.
• The deficiency in astrocyte generation and function may be a key factor contributing to white matter loss in VWM.
• These findings highlight a potential therapeutic target for VWM by addressing astrocyte dysfunction.